Back to Journals » Clinical Ophthalmology » Volume 13

Clinical Trial Report

A phase 2 randomized, double-masked, placebo-controlled study of novel nonsystemic kinase inhibitor TOP1630 for the treatment of dry eye disease

       
Total article views   HTML views PDF downloads Totals
11,165 Dovepress* 8,810+ 2,081 10,891
PubMed Central* 2,355 344 2,699
Totals 11,165 2,425 13,590
*Since 12 February 2019
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on PubMed Central and Google Scholar